Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,794 | 24,869 | 43,462 | 28,081 | 125,574 |
| Marketable Securities | 119,438 | 166,076 | 175,132 | 213,126 | 139,182 |
| Receivables | 377 | 687 | 509 | 725 | 481 |
| TOTAL | $185,949 | $202,923 | $227,771 | $249,813 | $270,064 |
| Non-Current Assets | |||||
| PPE Net | 2,242 | 2,409 | 2,549 | 2,693 | 2,794 |
| Other Non-Current Assets | 409 | 395 | 1,480 | 929 | 1,299 |
| TOTAL | $2,651 | $2,804 | $4,029 | $3,622 | $4,093 |
| Total Assets | $188,600 | $205,727 | $231,800 | $253,435 | $274,157 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,213 | 2,503 | 1,494 | 2,882 | 2,410 |
| Accrued Expenses | 9,068 | 12,411 | 15,864 | 3,266 | 2,782 |
| TOTAL | $11,922 | $17,636 | $17,358 | $15,422 | $14,473 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 2,053 |
| Other Non-Current Liabilities | 1,630 | 1,743 | 1,851 | 1,954 | 0 |
| TOTAL | $1,630 | $1,743 | $1,851 | $1,954 | $2,053 |
| Total Liabilities | $13,552 | $19,379 | $19,209 | $17,376 | $16,526 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,882 | 68,882 | 68,701 | 68,701 | 68,696 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -638,960 | -625,872 | -596,459 | -570,177 | -546,139 |
| Other shareholders' equity | -130 | 80 | 177 | 228 | 45 |
| TOTAL | $175,048 | $186,348 | $212,591 | $236,059 | $257,631 |
| Total Liabilities And Equity | $188,600 | $205,727 | $231,800 | $253,435 | $274,157 |